Chinese Heparin Testing Lab Warned by FDA

Drug Industry Daily
A A
A Chinese heparin contract testing lab has been warned by the FDA for significant cGMP violations, recalling unresolved questions and concerns from the Chinese heparin scandal a decade ago.

To View This Article:

Login

Subscribe To Drug Industry Daily